HSP90AA1 and neoplasm: Complete loss of Hsp90 function is lethal, as multiple essential pathways are inactivated, a feature exploited in cancer treatment, where tumour-cell growth is heavily dependent on mutated oncogenic proteins that require Hsp90 assistance to function during malignant progression (reviewed in [21] and [22]).